A detailed history of P Squared Asset Management Ag transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, P Squared Asset Management Ag holds 229,086 shares of ITCI stock, worth $30.2 Million. This represents 22.96% of its overall portfolio holdings.

Number of Shares
229,086
Holding current value
$30.2 Million
% of portfolio
22.96%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025

BUY
$81.78 - $131.92 $18.7 Million - $30.2 Million
229,086 New
229,086 $30.2 Million

Others Institutions Holding ITCI

About Intra-Cellular Therapies, Inc.


  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $12.4B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track P Squared Asset Management Ag Portfolio

Follow P Squared Asset Management Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of P Squared Asset Management Ag, based on Form 13F filings with the SEC.

News

Stay updated on P Squared Asset Management Ag with notifications on news.